您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > PKM2-IN-3
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
PKM2-IN-3
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
PKM2-IN-3图片
CAS NO:2408841-19-8
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
PKM2-IN-3 是PKM2激酶的抑制剂,IC50值为 4.1 μM。PKM2-IN-3 通过抑制 PKM2 介导的糖酵解和 NLRP3 激活,具有抗神经炎症的作用。
生物活性

PKM2-IN-3 is an inhibitor ofPKM2 kinasewith anIC50value of 4.1 μM. PKM2-IN-3 exhibits an anti-neuroinflammatory effect by inhibiting PKM2-mediated glycolysis andNLRP3activation[1].

IC50& Target[1]

PKM2

4.1 μM (IC50)

体外研究
(In Vitro)

PKM2-IN-3 (compound 10i) inhibits the TNF-α release of LPS-stimulated RAW264.7 macrophages, with an IC50value of 5.2 μM. PKM2-IN-3 exhibits the lowest toxicity with a CC50value of 43.6 μM[1].
PKM2-IN-3 (0.1-100 μM; 20 min) inhibits PKM2 kinase activity in a cell-free molecular level with an IC50value of 4.1 μM[1].

体内研究
(In Vivo)

PKM2-IN-3 (1, 10 mg/kg; i.p.; daily for 3 days ) significantly reverses the LPS-induced mice behavior changes in open field test[1].
PKM2-IN-3 (1, 10 mg/kg; i.v.; injected at 4 hours and 24 hours after ischemia onset) reduces the infarct volume and improves neurological deficits of tMCAO rats[1].

Animal Model:LPS-induced mice (male 6-8 weeks old; 20.0-22.0 g)[1]
Dosage:1, 10 mg/kg
Administration:i.p.; daily for 3 days
Result:Reversed the LPS-induced mice behavior changes in open field test.
Animal Model:tMCAO Sprague-Dawley rats (Male 8-10 weeks old; 250.0-280.0 g)[1]
Dosage:1, 10 mg/kg
Administration:i.v.; injected at 4 hours and 24 hours after ischemia onset
Result:Reduced the infarct volume and improved neurological deficits of tMCAO rats.
分子量

338.40

Formula

C21H22O4

CAS 号

2408841-19-8

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.